FDA

The U.S. Food and Drug Administration (FDA) is the federal agency that regulates drugs, medical devices, and other health products sold in the United States, and it has become a major regulator of AI-enabled medical software. It has authorized hundreds of AI and machine learning tools, such as diagnostic imaging aids, and has issued guidance on how developers should manage model changes, monitor performance after launch, and document training data. For companies building or buying AI in healthcare, FDA expectations shape clearance pathways, post-market obligations, and the evidence needed to defend a product in an audit or lawsuit.

1 item

ResearchUS2026-10-23

Microsoft Diagnostic AI Beats Doctors on Paper, But Lacks Clinical Clearance

Microsoft published peer-reviewed research in Science claiming its Diagnostic Orchestrator system achieved 83% diagnostic accuracy on complex cases, compared with 36% for physicians using references. The system is built on GPT-5 and uses multiple coordinating AI components. Microsoft acknowledged it requires clinical validation before deployment, while signaling near-term hospital pilots.

Microsoft healthcare AI clinical validation GPT-5 medical diagnosis FDA multi-agent AI high-risk AI